In a paper published in this journal in 1992 we looked at the relationship between central retinal artery and ocular neovascularisation in eight patients. 2 We agree with McLeod 3 that penumbral retinal tissue viability can persist as half of our patients did not fall into the carotid occlusive disease group. This concurs with Kottow and Hendrickson, 4 who found anterior segment neovascularisation following CRAO, as well as Brown, 5 who reported a case of neovascularisation following CRAO due to presumed single mitral valve embolus in the absence of carotid disease.
Varma et al also refer to preventing ocular neovascularisation following CRAO. The relationship between these two events is more complex than this paper implies, as we described in a table which I reproduce here for the sake of clarity ( Table 1) . As well as considering CRAO alone, it considers the concept of double embolism as reported by Wolter 6 as well as CRAO in a setting of chronic ocular ischaemia due to carotid occlusive disease. 7, 8 We do, however, strongly agree with Varma et al that such patients should be reviewed at regular intervals for at least 3 months following the diagnosis of CRAO.
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The author declares no conflict of interest. Neovascularisation is a process of unregulated and misguided growth of new vessels in the eye. 8 Many variables affect neovascularisation, including the extent of ischaemia. Thus, the time to ocular neovascularisation onset ranges from 2 weeks to 4 months post CRAO. 8 Ocular neovascularisation is principally due to chronic retinal ischaemia and multiple mediators. Vascular endothelial growth factor (VEGF) is highly implicated in its pathogenesis. 8 Neovascularisation in the eye is a maladaptive process occurring in ischaemic penumbral retinal tissue from events such as CRAO or ischaemic diabetic retinopathy, when there is insufficient blood supply to the retina. Neovascularisation results in an increased tendency to bleed, resulting in vitreous haemorrhage. If neovascularisation of the iris and angle occurs, this can result in neovascular glaucoma (NVG) with acute rise in intraocular pressure causing congestion and pain.
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We showed a clear empirical correlation between thromboembolic CRAO and ocular neovascularisation. 8 The overall rate of neovascularisation in our cohort was 18.2%, consistent with most other studies. In the majority of neovascularisation cases there were no clinical features of ocular ischaemia and no association with a haemodynamically significant stenosis of the carotid artery. Given the association between neovascularisation and CRAO, it is prudent to review all patients with acute CRAO at regular intervals as early as 2 weeks and up to 4 months post CRAO.
